Versartis

edit

Versartis is a biotechnology company developing therapeutic proteins for the treatment of metabolic diseases and endocrine disorders. The company was founded in December 2008 as a joint venture between Amunix and Index Ventures.

Milestones

edit

• Received $11M in Series A funding. (6/2/09)
  Posted 6/17/09 at 10:25am

Videos

Screenshots

edit

Sources

1. Start-up Versartis snags $11M for upcoming trials (fiercebiotech.com) [edit]